Merck KGaA says high asset prices call for prudent M&A approach
The CEO of Germany's Merck KGaA said a recovery in sales growth at its existing business means it can take a cautious approach when it comes to buying other companies, which are expensively priced.
STAT10h
Pharmalittle: We’re reading about RFK Jr. conflicts, new warnings on MS drugs, and more
Robert F. Kennedy Jr., Trump’s pick to be health secretary, is keeping his financial stake in major vaccine litigation ...
Suboxone MDL Mostly Survives Initial Preemption Challenge
The authors write "Suboxone is the brand name of combination of Buprenorphine and Naloxone, manufactured by Indivior, Inc., and used in the treatment of opioid dependence. In January of 2022, the FDA ...
Medindia18h
Tuberculosis Clinical Trial Pipeline Appears Robust With 30+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
Tuberculosis Pipeline Report Introduction 2. Tuberculosis Pipeline Report Executive Summary 3. Tuberculosis Pipeline: ...